title: Response to 'Comment on external multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'.
authors.affiliation: 1] Department of Obstetrics and Gynaecology, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris 6, Institut Universitaire de Cancérologie, Paris, France [2] INSERM UMR_S 707, 'Epidemiology, Information Systems, Modeling', University Pierre and Marie Curie, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Bendifallah
authors.affiliation: 1] Department of Obstetrics and Gynaecology, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris 6, Institut Universitaire de Cancérologie, Paris, France [2] INSERM UMR_S 938, Université Pierre et Marie Curie, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Darai
mesh_terms: D062625:Cystadenofibroma / Q000175:diagnosis*; D005260:Female; D006801:Humans; D049451:Nomograms; D010051:Ovarian Neoplasms / Q000175:diagnosis*
references.citation: J Clin Oncol. 2008 Mar 10;26(8):1364-70
references.pmid: 18323559
references.citation: Int J Gynecol Cancer. 2013 Feb;23(2):264-7
references.pmid: 23295940
references.citation: Br J Cancer. 2013 Nov 26;109(11):2774-7
references.pmid: 24169360
references.citation: Br J Cancer. 2014 Dec 9;111(12):2375
references.pmid: 24448362